期刊
PHARMACOGENETICS AND GENOMICS
卷 22, 期 4, 页码 310-318出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/FPC.0b013e32834f94cb
关键词
cardiovascular toxicity; colon cancer; COX-2; coxibs; celecoxib; CYP2C9; drug response; inflammation; nonsteroidal anti-inflammatory drugs; pathway; pharmacogenomics; selective COX-2 inhibitors
资金
- National Institutes of Health/National Institute of General Medical Sciences [U01GM61374]